InMed Pharmaceuticals (INM) has released an update.
InMed Pharmaceuticals has been granted a temporary exception by Nasdaq to implement a share consolidation in order to meet listing requirements. The company plans to consolidate its shares on a 1-for-20 basis, which will help it regain compliance with the minimum bid price rule. This move aims to enhance shareholder value and ensure continued trading on Nasdaq.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
